Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04247529 · ClinicalTrials.gov registry record · NA
Effects of Prior Exposure to Conflicting Health Information on Responses to Subsequent Unrelated Health Messages
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 6,046
- Enrollment target
NCT04247529: Completed NA study, sponsored by University of Minnesota.
NCT04247529 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 6,046 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (331% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04247529, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,046 participants
- Enrollment target
Study Summary
Many population-level public health strategies-including media campaigns and other behavioral interventions, screening recommendations, and vaccination policies-rely on messaging to promote cancer prevention and control. These strategies do not take place in a vacuum; rather, they occur in the context of a broader public information environment, which is increasingly characterized by conflicting and often controversial health information. Although studies have documented that such information is prevalent, a critical question remains unanswered: does exposure to conflicting health information in people's routine interactions with the broader information environment threaten the success of message-based population-level public health strategies? And, if so, who is most susceptible to the effects of such exposure? This study will provide a rigorous empirical test of these critical answered questions, guided by two specific aims: First, to evaluate whether prior exposure to conflicting health information influences responses to subsequent unrelated and uncontested health messages, a phenomenon that has been described as "carryover effects" (Primary Aim); and second, to identify whether there are individual-level differences in how conflict affects responses to these unrelated and uncontested health messages (Secondary Aim).
Primary Outcome
* Participants are asked to indicate how "the ad you just saw made you feel" * 7 affective responses are randomly ordered: interested, frustrated, surprised, annoyed, distressed, optimistic, worried (response options: 1 "very slightly or not at all" to 5 "extremely")
Interventions
- OTHER Exposure to conflicting health information
- OTHER No exposure to conflicting health information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,046 participants |
| Start Date | 2020-07-20 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
What the finished NCT04247529 record still lists
NCT04247529 is an interventional study that assigns participants to a tested intervention. Its 6,046 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (331% higher).
The record links to 0 conditions, and to 2 interventions - of which Exposure to conflicting health information is the first listed.
NCT04247529 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04247529 about?
NCT04247529 is a clinical study titled "Effects of Prior Exposure to Conflicting Health Information on Responses to Subsequent Unrelated Health Messages". Many population-level public health strategies-including media campaigns and other behavioral interventions, screening recommendations, and vaccination policies-rely on messaging to promote cancer prevention and control. These strategies do not take place in a vacuum; rather, they occur in the conte...
What is the current status of trial NCT04247529?
This trial is currently completed. It is a NA study. The enrollment target is 6,046 participants. The study started on 2020-07-20. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT04247529?
The interventions under investigation include: Exposure to conflicting health information (OTHER), No exposure to conflicting health information (OTHER).
Who is sponsoring clinical trial NCT04247529?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04247529's enrollment target sits among peer trials
6,046 22nd of 2000 higher than 1,979 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05884190 · 6,030 participants · NA
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
- NCT07166861 · 6,080 participants · NA
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI